Published April 9, 2026
| Version v1
Report
Open
The β-Grasp Fold: From Ubiquitin's Structure to Versatile Functions and Therapeutic Targeting
Authors/Creators
Description
The β-grasp fold represents a remarkable paradigm of structural efficiency and evolutionary exaptation in molecular biology. Characterized by a compact architecture in which a four- to five-stranded anti-parallel β-sheet grasps a central α-helix, this fold provides an exceptionally stable yet adaptable platform for diverse biochemical interactions. Evolutionary reconstructions trace the origins of the β-grasp fold back to the last universal common ancestor, where it initially participated in RNA metabolism and prokaryotic sulfur transfer systems. Over billions of years, the fold radiated into numerous functional niches, independently evolving capabilities for enzymatic catalysis, iron-sulfur cluster binding, and soluble ligand recognition, as seen in NUDIX phosphohydrolases, ferredoxins, and the SLBB superfamily, respectively.
In eukaryotes, the β-grasp fold experienced a dramatic evolutionary expansion, culminating in the ubiquitin and ubiquitin-like protein superfamilies. These proteins, including SUMO, NEDD8, and ISG15, function as critical post-translational modifiers. They are conjugated to target substrates via a highly coordinated enzymatic cascade involving E1 activating, E2 conjugating, and E3 ligating enzymes. This modification network, particularly the ubiquitin-proteasome system, regulates fundamental cellular processes such as protein degradation, DNA repair, cell cycle progression, and immune responses. The functional specificity of these pathways is dictated by varied ubiquitin chain linkages and specialized ubiquitin-binding domains that decipher these complex signals.
Given its central role in cellular homeostasis, dysregulation of β-grasp fold proteins is frequently implicated in severe pathologies, including cancer, neurodegenerative diseases, and viral infections. Consequently, the ubiquitin-proteasome system and ubiquitin-like protein pathways have emerged as prime targets for therapeutic intervention. Advanced experimental methodologies, including cryo-electron microscopy, NMR spectroscopy, cross-linking mass spectrometry, and molecular dynamics simulations, are actively employed to dissect the transient states and complex protein-protein interactions of these systems. By elucidating the precise structural mechanisms and allosteric networks governing β-grasp proteins, researchers are developing targeted therapeutics, such as proteasome inhibitors, E3 ligase modulators, and proteolysis-targeting chimeras, to combat diseases driven by proteostatic dysfunction.
Source: https://www.ubiquitinres.com/posts/the-grasp-fold-from-ubiquitins-structure-to-versatile-functions-and-therapeutic-targeting